Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge

Source: Kalmuk J, Puchalla J, Feng G, et al. Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge. Cancers Head Neck 5, 3 (2020). DOI:10.1186/s41199-020-0050-3

Please sign in or register for FREE

No comments yet.